The rising prevalence of chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, is expected to drive the demand for critical care services nationwide. Against this backdrop, the critical care ventilators market in India is set to grow at a compound annual growth rate (CAGR) of 4% between 2023 and 2033, forecasts GlobalData, a leading data and analytics company.

GlobalData’s latest report, “Ventilators Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033,” reveals that India critical care ventilator market accounted for approximately 21% of the Asia-Pacific market in 2023.

Kanchan Chauhan, Medical Devices Analyst at GlobalData, comments: “Urbanization and industrial expansion have worsened air pollution in India, leading to more respiratory diseases like COPD. The COVID-19 pandemic has further emphasized the need for ventilators in treating severe respiratory issues. Furthermore, an aging population and evolving disease trends have increased critical care admissions, as patients with severe respiratory illnesses often require intensive care and mechanical ventilation. This surge in demand has driven up the need for critical care services and equipment, including ventilators, in hospitals across the country.”

Swedish firm Getinge’s launch of the Servo-c mechanical ventilator marks a significant advancement in respiratory care solutions for pediatric and adult patients in India. Offering advanced monitoring capabilities, and modular component parts for efficient fleet management, the Servo-c surpasses traditional ventilators. Its essential functionalities, such as CO2 monitoring and Servo Compass, provide real-time insights into lung mechanics and gas exchange, enhancing treatment efficacy and operational efficiency for hospitals.

Chauhan concludes: “In conclusion, India’s healthcare sector is undergoing a remarkable evolution driven by technological progress, particularly evident in critical care ventilators. The nation’s proactive response to the rising prevalence of respiratory diseases and an aging population underscores its commitment to innovation, safety and improving public health outcomes.”